[go: up one dir, main page]

IE37266B1 - 15alpha 16alpha-methylene-delta4-oestren-17beta-ols - Google Patents

15alpha 16alpha-methylene-delta4-oestren-17beta-ols

Info

Publication number
IE37266B1
IE37266B1 IE190/73A IE19073A IE37266B1 IE 37266 B1 IE37266 B1 IE 37266B1 IE 190/73 A IE190/73 A IE 190/73A IE 19073 A IE19073 A IE 19073A IE 37266 B1 IE37266 B1 IE 37266B1
Authority
IE
Ireland
Prior art keywords
methylene
dimethyl
propylenedioxy
prepared
methyl
Prior art date
Application number
IE190/73A
Other versions
IE37266L (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IE37266L publication Critical patent/IE37266L/en
Publication of IE37266B1 publication Critical patent/IE37266B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

1425636 15,16 - Methylene - estr - 4 - enes SCHERING AG 12 Feb 1973 [11 Feb 1972] 6821/73 Heading C2U [Also in Division A5] Novel steroids of the formula wherein R<SP>1</SP> is C 1-5 alkyl; R<SP>2</SP> is H or acyl; R<SP>3</SP> is H or an optionally substituted aliphatic hydrocarbon group of at most 5 carbon atoms (exclusive of substituents); and X is O or H (OR<SP>4</SP>) in which OR<SP>4</SP> is in the alpha or beta position and R<SP>4</SP> is H or acyl are prepared from steroids of the formulµ wherein Y is a protected keto group and the dotted lines in the rings indicate the presence of a #<SP>5</SP>- or #<SP>5(10)</SP>-double bond and when a #<SP>5(10)</SP>- double bond is present then the 10-H atom is absent, by reduction in the 17-position or conversion to a 17α-substituted-17#-ol followed when required, by hydrolysis to a free #<SP>4</SP>-3-one and, if desired, by hydrogenation of a 17α- unsaturated group and/or reduction to a 3-ol and/or acylation of a free OH group. 3,3 - (2<SP>1</SP>,2<SP>1</SP> - Dimethyl - 1<SP>1</SP>,3<SP>1</SP> - propylenedioxy)- 18 - methyl - 15α,16α - methylene - #<SP>5</SP> or #<SP>5(10)</SP>- estren-17-one is prepared from 3,3-(2<SP>1</SP>,2<SP>1</SP>-dimethyl - 1<SP>1</SP>,3<SP>1</SP> - propylenedioxy) - 18 - methyl - 19- nor - #<SP>5,16</SP> or <SP>15(10),16</SP> - pregnadien - 20 - one (prepared from the #<SP>4</SP>-3-one and 2,2-dimethyl-1,3- propane-diol) by oxygenation to give the corresponding #<SP>15</SP> - 17α - ol, reduction of this to the corresponding 20-ol, reaction of this with methylene iodide in the presence of a Zn-Cu couple to give 17α,20# - dihydroxy - 3,3 - (2<SP>1</SP>,2<SP>1</SP>- dimethyl - 1<SP>1</SP>,3<SP>1</SP> - propylenedioxy) - 18 - methyl- 15α,16α - methylene - 19 - nor - #<SP>5</SP>- or #<SP>5(10)</SP>- pregnene and oxidation of this. 3,3-(2<SP>1</SP>,2<SP>1</SP> -dimethyl - 1<SP>1</SP>,3<SP>1</SP> - propylenedioxy) - 15α,16α- methylene - #<SP>5</SP> or <SP>15(10)</SP> - estren - 17 - one is prepared similarly via corresponding intermediates. The novel steroids are stated to possess a strong androgenic and anabolic activity or a strong gestagenic activity and they may be made up into pharmaceutical compositions with suitable carriers. The gestagenic compounds can be used, possibly together with estrogens, in contraceptive preparations (see Heading A5B). [GB1425636A]
IE190/73A 1972-02-11 1973-02-06 15alpha 16alpha-methylene-delta4-oestren-17beta-ols IE37266B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (en) 1972-02-11 1972-02-11 15?, 16? -Methylene-4-oestrene-17? -ols or acylates, processes for their production and medicaments containing them

Publications (2)

Publication Number Publication Date
IE37266L IE37266L (en) 1973-08-11
IE37266B1 true IE37266B1 (en) 1977-06-08

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
IE190/73A IE37266B1 (en) 1972-02-11 1973-02-06 15alpha 16alpha-methylene-delta4-oestren-17beta-ols

Country Status (29)

Country Link
JP (1) JPS5829317B2 (en)
KR (1) KR780000156B1 (en)
AT (1) AT327413B (en)
AU (1) AU467306B2 (en)
BE (1) BE795241A (en)
CA (1) CA997753A (en)
CH (2) CH590883A5 (en)
CS (1) CS193019B2 (en)
DD (1) DD102379A5 (en)
DE (1) DE2207421C3 (en)
DK (1) DK131037B (en)
EG (1) EG10914A (en)
ES (1) ES410933A1 (en)
FI (1) FI52225C (en)
FR (1) FR2181719B1 (en)
GB (1) GB1425636A (en)
GR (1) GR63160B (en)
HU (1) HU165253B (en)
IE (1) IE37266B1 (en)
IL (1) IL41506A (en)
NL (1) NL177217C (en)
NO (2) NO140304C (en)
PH (1) PH9370A (en)
PL (1) PL81084B1 (en)
RO (1) RO73527A (en)
SE (3) SE403781B (en)
SU (1) SU513628A3 (en)
YU (1) YU35035B (en)
ZA (1) ZA73944B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027637A1 (en) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17β-cyano-19-nor-androst-4-ene derivative, its use and the derivative-containing drug
DE102007027636A1 (en) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17β-Cyano-18α-homo-19-nor-androst-4-ene derivative, its use and the derivative-containing drug

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (en) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stackable, rectangular, closed plastic transport container for fine-grained bulk goods and liquids

Also Published As

Publication number Publication date
DE2207421C3 (en) 1981-05-07
NO143065B (en) 1980-09-01
AU467306B2 (en) 1975-11-27
GR63160B (en) 1979-09-25
RO73527A (en) 1982-02-01
CH590883A5 (en) 1977-08-31
CH593995A5 (en) 1977-12-30
SE7514513L (en) 1975-12-22
KR780000156B1 (en) 1978-05-02
DE2207421B2 (en) 1980-07-24
JPS4886856A (en) 1973-11-15
HU165253B (en) 1974-07-27
YU35035B (en) 1980-06-30
PH9370A (en) 1975-10-22
BE795241A (en) 1973-08-09
FR2181719B1 (en) 1975-11-21
SE7713896L (en) 1977-12-07
FR2181719A1 (en) 1973-12-07
PL81084B1 (en) 1975-08-30
ZA73944B (en) 1973-11-28
GB1425636A (en) 1976-02-18
NO143065C (en) 1980-12-10
NL7301974A (en) 1973-08-14
NO140304B (en) 1979-04-30
ES410933A1 (en) 1976-03-01
JPS5829317B2 (en) 1983-06-22
NO140304C (en) 1979-08-08
SE403781B (en) 1978-09-04
DK131037B (en) 1975-05-20
IL41506A (en) 1976-07-30
FI52225B (en) 1977-03-31
AU5207673A (en) 1974-08-15
CA997753A (en) 1976-09-28
NL177217C (en) 1985-08-16
IE37266L (en) 1973-08-11
DK131037C (en) 1975-10-20
AT327413B (en) 1976-01-26
EG10914A (en) 1976-09-30
CS193019B2 (en) 1979-09-17
SE409329B (en) 1979-08-13
NO782754L (en) 1973-08-14
FI52225C (en) 1977-07-11
NL177217B (en) 1985-03-18
ATA112473A (en) 1975-04-15
SE426834B (en) 1983-02-14
DE2207421A1 (en) 1973-08-16
DD102379A5 (en) 1973-12-12
IL41506A0 (en) 1973-04-30
YU24373A (en) 1979-12-31
SU513628A3 (en) 1976-05-05

Similar Documents

Publication Publication Date Title
GB1515284A (en) Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
GB1163737A (en) Improvements in or relating to 7-Dihalomethyl Steroids
US3309387A (en) 19-lower alkyl androstanes and pregnanes
DAVIES et al. Estrogen synthesis by adrenal-placental tissues of the sheep and the iris monkey in vitro
Hassner et al. The Cleavage Reaction of 16-Oximino-17-keto Steroids1
IE37266L (en) 15Ó, 16Ó - METHYLENE -DELTA 4 - OESTREN - 17ß - OLS.
US3284477A (en) Diuretic 1, 4, 9(11)-pregnatrienes
ES8506326A1 (en) Estrane and androstane derivatives, process for their preparation and pharmaceutical preparations containing them
GB1147803A (en) Improvements in or relating to novel steroids and the manufacture thereof
GB1502326A (en) 11-substituted steroids of the estrane series
US2837517A (en) 9, 11beta-epoxy-17-alkyltestosterones
GB1504410A (en) 11beta-fluoroandrostenes
GB1146992A (en) Improvements in or relating to novel steroids and the manufacture thereof
GB1472922A (en) Pregnanoic acid derivatives
GB1190404A (en) 4,4-Dihydroxy-2-Butenoic Acid Lactones
CA1069117A (en) PROCESS FOR THE PREPARATION OF 11.beta.-HYDROXY-18-ALKYL-ESTRANE COMPOUNDS
GB1450807A (en) Cardenolide glycosides and process for their manufacture
GB1260398A (en) NEW 18-METHYL-5alpha-H-ANDROSTANES
GB1140642A (en) 17-‡-cyanoethynyl-steroids
GB1514621A (en) 13-ethynyl-and 13-(2-halovinyl)-steroids and their preparation
GB1304395A (en)
US3452060A (en) 17-hydroxy-17-(3-oxo-1-propynyl or-propenyl) steroids
GB1206874A (en) 7alpha-METHYL-6&amp;beta,19-OXIDO-ANDROSTANE COMPOUNDS
US3174984A (en) 3-hydroxy and acyloxy-6, 16-dialkyl-17-oxygenated-20-ketopregnenes
US3479435A (en) Dithioketals of delta-4,9-3-ketosteroids